Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
46
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer

Sho NakamuraDepartment of Clinical Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan
,
Tadahisa FukuiDepartment of Clinical Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan
,
Shuhei SuzukiDepartment of Clinical Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan
,
Hiroyuki TakedaDepartment of Clinical Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan
,
Kaname WatanabeDepartment of Clinical Oncology, Yamagata University Faculty of Medicine, Yamagata, Japan
&
Takashi YoshiokaDepartment of Clinical Oncology, Yamagata University Faculty of Medicine, Yamagata, JapanCorrespondence[email protected]
Pages 1143-1147 | Published online: 23 Feb 2017

References

  • LimDHLeeSIParkKWBone marrow metastasis of colon cancer as the first site of recurrence: a case reportOncol Lett2014862672267425364447
  • XiaoLLuxiSYingTYizhiLLingyunWQuanPDiagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samplesJ Cancer Res Clin Oncol2009135568769318956213
  • HungYSChouWCChenTDPrognostic factors in adult patients with solid cancers and bone marrow metastasesAsian Pac J Cancer Prev2014151616724528082
  • NakashimaYTakeishiKGuntaniARectal cancer with disseminated carcinomatosis of the bone marrow: report of a caseInt Surg201499551852225216414
  • NaitoMYoshidaYAisuNA report of disseminated carcinomatosis of the bone marrow originating from transverse colon cancer successfully treated with chemotherapy using XELOX plus bevacizumabCase Rep Oncol20147242643425126072
  • International union against cancerTNM classification of malignant tumors7th edSobinLGospodarowiczMWittekindCNew YorkWiley-Blackwell2010
  • National Cancer InstituteCommon Terminology Criteria for Adverse Events v4.0NCI, NIH, DHHS NIH publication # 09-74732009
  • Van CutsemECervantesAAdamRESMO consensus guidelines for the management of patients with metastatic colorectal cancerAnn Oncol20162781386142227380959
  • HeinemannVStintzingSModestDPGiessen-JungCMichlMMansmannUREarly tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)Eur J Cancer201551141927193626188850
  • HeinemannVModestDPFischerWLGender and tumor location as predictors for efficacy: influence on endpoints in first-line treatment with FOLFIRI in combination with cetuximab or bevacizumab in the AIO KRK 0306 (FIRE3) trialJ Clin Oncol201432 Suppl; abstr 3600
  • AlanPVDonnaNFedericoIImpact of primary (1°) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB/SWOG 80405 (Alliance)J Clin Oncol201634 Suppl; abstr 3504

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.